Editorial
doi: 10.1086/650545.
When do minority drug-resistant HIV-1 variants have a major clinical impact?
- PMID: 20102273
- DOI: 10.1086/650545
Item in Clipboard
Editorial
When do minority drug-resistant HIV-1 variants have a major clinical impact?
J Infect Dis.
2010 Mar.
No abstract available
Comment on
-
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.J Infect Dis. 2010 Mar;201(5):662-71. doi: 10.1086/650543. J Infect Dis. 2010. PMID: 20102271 Free PMC article.
-
Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients.J Infect Dis. 2010 Mar;201(5):672-80. doi: 10.1086/650542. J Infect Dis. 2010. PMID: 20102272 Free PMC article.
Similar articles
-
Detection and significance of minority quasispecies of drug-resistant HIV-1.J HIV Ther. 2006 Dec;11(4):74-81. J HIV Ther. 2006. PMID: 17578210 Review. No abstract available.
-
Rapid selection and archiving of mutation E157Q in HIV-1 DNA during short-term low-level replication on a raltegravir-containing regimen.J Antimicrob Chemother. 2009 Aug;64(2):433-4. doi: 10.1093/jac/dkp182. Epub 2009 May 20. J Antimicrob Chemother. 2009. PMID: 19457931 No abstract available.
-
Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.J Clin Virol. 2004 May;30(1):24-31. doi: 10.1016/j.jcv.2003.08.001. J Clin Virol. 2004. PMID: 15072750
-
HIV-1 drug resistance in variants from the female genital tract and plasma.J Infect Dis. 2007 Feb 15;195(4):535-45. doi: 10.1086/510855. Epub 2007 Jan 8. J Infect Dis. 2007. PMID: 17230413
-
Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes.AIDS Rev. 2006 Apr-Jun;8(2):98-107. AIDS Rev. 2006. PMID: 16848277 Review.
Cited by
-
Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques.Antimicrob Agents Chemother. 2012 May;56(5):2251-8. doi: 10.1128/AAC.05810-11. Epub 2012 Feb 13. Antimicrob Agents Chemother. 2012. PMID: 22330914 Free PMC article.
-
Factors limiting the transmission of HIV mutations conferring drug resistance: fitness costs and genetic bottlenecks.Sci Rep. 2012;2:320. doi: 10.1038/srep00320. Epub 2012 Mar 19. Sci Rep. 2012. PMID: 22432052 Free PMC article.
-
Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infection.PLoS One. 2011;6(7):e21734. doi: 10.1371/journal.pone.0021734. Epub 2011 Jul 6. PLoS One. 2011. PMID: 21754996 Free PMC article. Clinical Trial.
-
Transmitted HIV resistance to first-line antiretroviral therapy in Lima, Peru.AIDS Res Hum Retroviruses. 2012 Apr;28(4):333-8. doi: 10.1089/aid.2011.0131. Epub 2011 Aug 5. AIDS Res Hum Retroviruses. 2012. PMID: 21819256 Free PMC article.
-
Short-course Combivir after single-dose nevirapine reduces but does not eliminate the emergence of nevirapine resistance in women.Antivir Ther. 2012;17(2):327-36. doi: 10.3851/IMP1946. Epub 2011 Nov 3. Antivir Ther. 2012. PMID: 22293443 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
